Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
‘Neuroethics: The Implications of Mapping and Changing the Brain,’ an excerpt
In his new book, published today, philosopher Walter Glannon examines the ethics of six areas of neuroscience. In Chapter 4, a portion of which appears below, he tackles the ethical considerations of using brain organoids in research.
‘Neuroethics: The Implications of Mapping and Changing the Brain,’ an excerpt
In his new book, published today, philosopher Walter Glannon examines the ethics of six areas of neuroscience. In Chapter 4, a portion of which appears below, he tackles the ethical considerations of using brain organoids in research.
Teasing out mosaicism cell by cell; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 10 November.
Teasing out mosaicism cell by cell; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 10 November.
Without monkeys, neuroscience has no future
Research in primate brains has been essential for the development of brain-computer interfaces and artificial neural networks. New funding and policy changes put the future of such advances at risk.
Without monkeys, neuroscience has no future
Research in primate brains has been essential for the development of brain-computer interfaces and artificial neural networks. New funding and policy changes put the future of such advances at risk.